BridgeMD
New treatment option for Infertility, Male
Official title Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy.
ClinicalTrials.gov ID: NCT06384794
What this study is testing
- What it's testing
- It has been described that 11% of men with semen values within the normal range established by the World Health Organization (WHO) have sperm DNA fragmentation. This has been associated with a lower fertilization rate, lower embryo development and, therefore, lower reproductive success.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Couples undergoing an ICSI cycle with PGT-A (Preimplantational Genetic Test for Aneuploidy).
- Males over 18 years of age whose semen sample meets the basic conditions predetermined by the ZyMōt Multi 850µL chip.
- Fresh semen samples.
- Embryos are to be deposited in a time-lapse incubator.
- Women over 37 years of age who have obtained in follicular puncture a number of MII oocytes greater than or equal to 4.
You likely can't join if
- Males with severe asthenozoospermia (\<10% progressively motile spermatozoa), globozoospermia (spermatozoa with morphological alterations and lack of...
- Seminal samples obtained by testicular biopsy.
- Samples incubated with calcium ionophore.
- Males and females with previously known abnormal karyotype.
- Oocytes coming from the oocyte donation program.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Spain
- Valencia, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Spain; Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.